The Importance of Testing for BRAF Status in CRC Patients

Johanna Bendell, MD

Special Reports, Gastrointestinal Cancers (Issue 2), Volume 2, Issue 1

Johanna Bendell, MD, director of GI Cancer Research Program, associate director, Drug Development Program, Sarah Cannon Research Institute, discusses the importance of testing CRC patients for BRAF status.

Johanna Bendell, MD, director of GI Cancer Research Program, associate director, Drug Development Program, Sarah Cannon Research Institute, discusses the importance of testing CRC patients for BRAF status.

View information about palliative resection in mCRC > >